Funded Tech Companies
Pandion Therapeutics
Wondering who provided funding to Pandion Therapeutics? SR One Capital Management, Roche Venture Fund and Access Industries joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Pandion Therapeutics
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
610 Main St.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
Pandion Therapeutics is a biotechnology company developing bispecific antibody therapeutics to achieve localized immunomodulation at the site of disease for durable, tissue-specific treatment of patients with autoimmune and inflammatory disease and organ transplants.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/17/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Rahul Kakkar
Chief Operating Officer
Ed Freedman
Chief Scientific Officer
Jo Viney
VP - Bus. Development
Vikas Goyal
VP - Engineering
Hussam Shaheen
Company Investors
- SR One Capital Management (Vikas Goyal)
- Roche Venture Fund (Mitchell Mutz)
- Access Industries (Daniel Becker)
- OrbiMed
- Polaris Partners (Alan Crane)
- Boxer Capital (Christopher Fuglesang)
- BioInnovation
- Versant Ventures (Carlo Rizzuto)
- RA Capital
- JDRF T1D Fund (Jonathan Behr)
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs